Advertisement

Topics

Biological Mimetics, Inc., Company Profile

18:54 EDT 20th September 2018 | BioPortfolio

Biological Mimetics, Inc. (“BMI”) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine.
Our mission philosophy is to remain a creative and innovative biotechnology firm dedicated to improving the quality of life and overall state of public health through the application of novel technologies for the development and commercialization of human and veterinary biologics to address a long list of hitherto intractable disease targets involving viruses, bacteria, parasites, and cancer.

Based on the Company’s elucidation of a common vaccine evading mechanism of antigenic variation known as “Deceptive Imprinting” used by microbial pathogens and cancer cells, the company has developed a proprietary core technology termed “Immune Dampening and Refocusing”, which uses immune dampening and refocusing to circumvent such evasion mechanisms to: (1) generate vaccines against pathogens for which no effective vaccine exists and (2) improve on the strain or serotype restricted protection of previously tried and currently licensed and used human and veterinary vaccines. In addition, the technology is able to alter the natural antigenicity and immunogenicity of targeted protein antigens to induce and select for unique monoclonal antibodies that can be used for therapeutic, diagnostic, and research purposes. Therapeutic proteins and biologics can also be immune dampened to improve on their biological half-life and safety profiles.

Location

124 Byte Drive,
Frederick
Maryland
21702
United States of America

Contact

Phone: (301) 620-7565
Fax: (301) 620-1827
Email: info@bmi-md.com


News Articles [220 Associated News Articles listed on BioPortfolio]

HDL Mimetics Do Not Enhance Coronary Artery Plaque Regression

Two HDL mimetics containing apolipoprotein A-I (apoA-I) do not enhance regression of coronary-artery plaque in patients with acute coronary syndrome (ACS), according to results from two randomized cli...

Combining bh3-Mimetics to target both bcl-2 and mcl1 has potent activity in pre-clinical models of acute myeloid leukemia

Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates

Mid-infrared biosensor distinguishes multiple analytes in heterogeneous biological samples

Detecting biomolecules, such as lipids, proteins, and nucleic acids and their interactions in heterogeneous biological samples is crucial for understanding a multitude of biological mechanisms in heal...

Brazilian oncologists favour ‘follow-on biological products’

The Brazilian Society of Clinical Oncology (SBOC) has issued a position statement on ‘follow-on biological products’ in oncology. The statement reflects the society’s views on issues such as nam...

Tackling the Legislation Muddle of Human Biological Samples

They might sound mundane to the inexperienced layperson, but to scientists human biological samples (HBS) are, there is no other word for it, precious. Not only are HBS a basic need for fundamental re...

Bridging the gaps in global conservation

(American Institute of Biological Sciences) The BioScience Talks podcast features discussions of topical issues related to the biological sciences.

Innovations and New Approaches for Biological Drugs

Presenters delved into the topic of biological drugs and gene therapy during the recent International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland.

PubMed Articles [597 Associated PubMed Articles listed on BioPortfolio]

Selective BH3-mimetics targeting BCL-2, BCL-XL or MCL-1 induce severe mitochondrial perturbations.

Induction of apoptosis by selective BH3-mimetics is currently investigated as a novel strategy for cancer treatment. Here, we report that selective BH3-mimetics induce apoptosis in a variety of hemato...

Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.

Nuclear factor κB (NF-κB) is a transcription factor important for regulating innate and adaptive immunity, cellular proliferation, apoptosis, and senescence. Dysregulation of NF-κB and its upstream...

Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.

Exosomes are endogenous nanocarriers that can deliver biological information between cells. They are secreted by all cell types, including immune cells such as natural killer (NK) cells. However, mamm...

Polymersomes as nanoreactors for preparative biocatalytic applications: current challenges and future perspectives.

Polymersomes are hollow, spherical vesicles that are surrounded by a polymer membrane. The applied polymer must be amphiphilic to promote self-assembly in aqueous solution. At the same time, the polym...

Synthesis of α,α-Difluorinated Phosphonate pSer/pThr Mimetics via Rhodium-Catalyzed Asymmetric Hydrogenation of β-Difluorophosphonomethyl α-(Acylamino)acrylates.

A novel and facile synthetic strategy for α,α-difluorinated phosphonate mimetics of phosphoserine/phosphothreonine utilizing rhodium-catalyzed asymmetric hydrogenation was developed. The dehydrogena...

Clinical Trials [1554 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of Exenatide Injection in Subjects With Type 2 Diabetes Mellitus

Exenatide is the first in a new class of drugs for the treatment of type 2 diabetes mellitus called incretin mimetics. Exenatide resembles a gut hormone, which increases the insulin secret...

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more cancer...

Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer

RATIONALE: Learning about the effects of chemotherapy and biological therapy on nerve function may help doctors plan treatment and help patients live more comfortably. PURPOSE: This clini...

Development of Clinical and Biological Database

The BCB is a tool: - for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic tr...

Biological Therapy in Treating Women With Stage IV Breast Cancer

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor ...

Companies [649 Associated Companies listed on BioPortfolio]

Biological Mimetics, Inc.,

Biological Mimetics, Inc. (“BMI”) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and...

Annovis

Annovis, Inc. (Annovis) is a specialty chemicals company that is focused on staking out a leading position in the "mimetics" field. Mimetics are chemically modified biomolecules that, by virtue of suc...

Provid Pharmaceuticals Inc.

Provid Pharmaceuticals Inc. is a drug discovery company engaged in the identification of novel lead compounds for pharmaceutical development and providing expert collaborative research services to the...

Senn Chemicals AG

SENN CHEMICALS was founded in 1963 by Mr. Guido Senn in Dielsdorf, near Zürich. The main purpose was and still is to manufacture fine chemicals in a high quality standard. Initially, the product rang...

Biological E Limited

Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...

More Information about "Biological Mimetics, Inc.," on BioPortfolio

We have published hundreds of Biological Mimetics, Inc., news stories on BioPortfolio along with dozens of Biological Mimetics, Inc., Clinical Trials and PubMed Articles about Biological Mimetics, Inc., for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biological Mimetics, Inc., Companies in our database. You can also find out about relevant Biological Mimetics, Inc., Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record